IRVINE, Calif., July 15, 2015 /PRNewswire/ -- NuGene, Inc. ("NuGene") (OTCQB: NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, has announced that Chief Designer and Brand Ambassador Kathy Ireland will be featuring the company on her show, Worldwide Business with kathy ireland®. The program will air July 19, 2015 at 5:30pm ET on Fox Business Network and on Bloomberg International at 8:30am CET, 3:00pm HKT, and 10:30am CDT.
The program will showcase how NuGene is changing the cosmeceutical industry by offering a proprietary formula for skin and hair care, derived from Human Stem Cell Adipose Media, which contain multiple human growth factors, polypeptides, vitamins, amino acids, and minerals that can help reduce the signs of aging.
"Kathy is the perfect person to introduce NuGene to the public," said Mr. Ali Kharazmi, CEO of NuGene. "She is a respected and admired business mogul whose name is one of the most trusted brands in the world. We couldn't think of anyone who could better introduce NuGene to the world."
"NuGene is the first and only stem cell program to be branded as a kathy ireland product. It has been a long journey of discovery, to find a program that is truly best for me. With education and growth, we are confident to say, NuGene is truly incredible. It is based on genius, science and passion. Skin care is an area we've investigated, tested and tried for decades. There is nothing like NuGene... Miracles happen," stated Kathy Ireland, Chair and CEO of kathy ireland® Worldwide.
NuGene has recently published the results of three independent studies validating the products' ability to restore mature and damaged skin. The products were also recently selected to be carried as a premium brand by the leading dermatologist-owned skin care site, www.lovelyskin.com.
About NuGene, Inc.
NuGene International, Inc. specializes in developing, manufacturing and marketing proprietary regenerative cosmeceutical and pharmaceutical products based on adipose derived human stem cell and human stem cell media. The US Department of Health and Human Services calls regenerative medicine the "next evolution of medical treatments." The regenerative medical market which includes cosmeceuticals and pharmaceuticals was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report. NuGene's cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene's exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company has four patents pending covering 15 unique applications. NuGene's goal is to leverage its knowledge and expertise to develop age defying cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.
SOURCE NuGene, Inc.